期刊文献+

奥硝唑血药浓度的高效液相色谱法测定及其药动学研究 被引量:3

Determination of ornidazole in plasma by HPLC and study on its pharmacokinetics
暂未订购
导出
摘要 目的 建立血浆中奥硝唑浓度的反相高效液相色谱分析方法 ,并用此法研究奥硝唑的人体药动学。方法 采用Kro masilC18色谱柱 ,以甲醇 0 .4 %HAc(5 0∶5 0 )为流动相 ,流速 0 .8mL·min-1,紫外检测波长 316nm。结果 奥硝唑在 2 .0~2 0 .0 μg·mL-1范围内呈线性 ,r =0 .9997,最低检测限 0 .2 μg·mL-1。低、中、高浓度 (2 .0 ,10 .0 ,2 0 .0 μg·mL-1)的方法回收率分别为 10 0 .36 % ,98.2 1%和 97.4 2 % ,日间及日内RSD分别 <6 %和 <7%。药动学研究表明 ,口服奥硝唑国产与进口制剂的药 时曲线符合有滞后时间的二室模型。结论 本法准确可靠 ,操作简便 ,适用于临床药动学研究及常规血药浓度监测。 OBJECTIVE: A reversed HPLC method was established for the determination of ornidazole in human plasma. Its pharmacokinetic investigation was studied in healthy volunteers. METHODS: The drug was extracted from plasma with methanol and isopropanol (50:50), and then detected by UV detector at 316nm with a C 18 5 μm, 250 nm × 4.6 mm column. The mixture of methanol and 0.4% glacial acetic acid (50:50) was used as the mobile phase. The flow rate was 0.8 mL&middotmin-1. RESULTS. The calibration curve was linear over the range of 2.0∼20.0 μg&middotmL-1 and the measurable limit of detection was 0.2 μg&middotmL-1. The average recoveries of ornidazole at the concentrations of 2.0, 10.0, 20.0 μg&middotmL-1 were 100.36%, 98.21% and 97.42%, respectively. The RSDs of the within-day and between-day variations were less than 7% and 6% respectively. The results showed that the concentration time curves of the two preparations were fitted to a two compartment model with a lag time. CONCLUSION: This HPLC method is simple, sensitive and accurate. It is suitable for routine determination of ornidazole levels in human plasma and for its pharmacokinetic study.
出处 《中国药学杂志》 EI CAS CSCD 北大核心 2003年第9期690-692,共3页 Chinese Pharmaceutical Journal
关键词 奥硝唑 血药浓度 高效液相色谱法 测定 药动学 Acetic acid High performance liquid chromatography Methanol Pharmacokinetics Ultraviolet detectors
  • 相关文献

参考文献4

  • 1Merdjan H, Bonnat C, Singlas E, et al. Measurement of omidazole by high performance liquid chromatography [ J ]. J Chromatogr, 1983,273 : 475.
  • 2Heimmnn P,Gesehke R,Zinapold K. Determination of omidazole and its main metabolites in biological fluids [J]. J Chromatogr,1990,534:233.
  • 3Martin C, Bruguerolle B, MaUet N, et od. Pharmacokinetics and tissue penetration of a single dose of omidazole for antibiotic prophylaxis in colorectal surgery [J ]. Antimicrob Agents Chemother, 1990,34:1921.
  • 4Turcant A, Granry JC, AUain P, et al. Pharmacokinetics of omidazole in neonates and infants after a tingle intravenous infusion [J]. Eur J Clin Pharmcol , 1987,32:111.

同被引文献17

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部